CTC 10 %w/w Oral Powder

Pays: Irlande

Langue: anglais

Source: HPRA (Health Products Regulatory Authority)

Ingrédients actifs:

Chlortetracycline hydrochloride

Disponible depuis:

Univet Limited

Code ATC:

QJ01AA03

DCI (Dénomination commune internationale):

Chlortetracycline hydrochloride

Dosage:

10 percent weight/weight

forme pharmaceutique:

Oral powder

Type d'ordonnance:

POM: Prescription Only Medicine as defined in relevant national legislation

Groupe thérapeutique:

Cattle, Pigs

Domaine thérapeutique:

chlortetracycline

indications thérapeutiques:

Antibacterial

Statut de autorisation:

Authorised

Date de l'autorisation:

1988-10-01

Résumé des caractéristiques du produit

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
CTC 10% w/w Oral Powder
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each g contains
ACTIVE SUBSTANCE
Chlortetracycline hydrochloride
100 mg
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Oral Powder.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Calves (less than 6 months of age) and pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Calves:
The product is indicated as an aid in the treatment of respiratory
disease in calves caused by_ Pasteurella spp_., sensitive
to chlortetracycline.
Pigs:
The product is indicated as an aid in the treatment of respiratory
disease in pigs caused by micro-organisms sensitive to
chlortetracycline.
4.3 CONTRAINDICATIONS
Do not use in adult ruminants, dairy cows and veal calves.
Do not use in animals with known hypersensitivity to the active
ingredient.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_8_
_/_
_0_
_1_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_4_
_9_
_2_
_4_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Inappropriate use of the product may increase the prevalence of
bacteria resistant to chlortetracycline and may decrease
the effectiveness of treatment with related substances, due to the
potential for cross-resistance.
Use of the product
should be based on susceptibility testing of the bacteria